{"id":61588,"date":"2025-05-20T11:01:27","date_gmt":"2025-05-20T09:01:27","guid":{"rendered":"https:\/\/ticker-noticiasep.microcontenidos.com\/NoticiaRSS.vbhtml?user=FRND562DLP&amp;cod=20250520110127"},"modified":"2025-05-20T11:01:27","modified_gmt":"2025-05-20T09:01:27","slug":"mundo-maren-thurow-starts-as-new-head-global-communications-at-grunenthal","status":"publish","type":"post","link":"https:\/\/webciudadana.net\/?p=61588","title":{"rendered":"Mundo: Maren Thurow starts as new Head Global Communications at Gr\u00fcnenthal"},"content":{"rendered":"\n<div><img decoding=\"async\" src=\"https:\/\/img.europapress.es\/fotoweb\/fotonoticia_20250520110127_300.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p>(Informaci\u00f3n remitida por la empresa firmante)<\/p>\n<p>\nAachen, Germany, 20th May 2025 (News Aktuell) .- Maren Thurow has today assumed the role of Vice President and Head Global Communications at Gr\u00fcnenthal. She succeeds Florian Dieckmann, who has played a key role in evolving the company\u2019s Communications department since 2021. In her new position, Maren will oversee Gr\u00fcnenthal\u2019s communications operations across all markets and lead the team based at the company\u2019s headquarters in Aachen. She will report directly to CEO Gabriel Baertschi.<\/p>\n<p> This appointment comes at a pivotal moment in Gr\u00fcnenthal\u2019s transformation, following the company\u2019s outstanding financial performance in 2024. Since 2017, Gr\u00fcnenthal\u2019s profitability, measured by adjusted EBITDA, has more than tripled, driven by strategic acquisitions and partnerships such as the acquisition of the US company Valinor Pharma and the product Movantik\u2122 in July 2024. Additionally, Gr\u00fcnenthal continues to advance its key R&amp;D programs, including progressing the Glucocorticoid Receptor Modulator (GRM) and Nociceptin (NOP) Receptor Agonist programs to the next development stages, along with ongoing progress in its Nav compounds. The company is also focusing on accelerating growth in Qutenza\u2122 and its Established Brands, while ensuring a smooth integration of Valinor Pharma and pursuing further strategic acquisitions.<\/p>\n<p> Maren joined Gr\u00fcnenthal in 2021 as Head of Global Commercial Communication and was subsequently the Planning Director for the company\u2019s commercial organization. Prior to joining Gr\u00fcnenthal Maren was a Director at FleishmanHillard, one of the world\u2019s leading global PR firms.<\/p>\n<p> About Gr\u00fcnenthal<\/p>\n<p>\nGr\u00fcnenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better \u2013 and innovation is our passion. We focus all our activities and efforts on working towards our vision of a World Free of Pain.<\/p>\n<p> Gr\u00fcnenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. Our products are available in approx. 100 countries. In 2024, Gr\u00fcnenthal employed around 4,300 people and achieved revenues of \u20ac1.8 billion.<\/p>\n<p> More information: https:\/\/www.grunenthal.com<\/p>\n<p>\nFollow us on: LinkedIn: Grunenthal Group<\/p>\n<p>\nInstagram: grunenthal<\/p>\n<p>\nClick here for our Gr\u00fcnenthal Report 2024\/2025<\/p>\n<p>\nFor further information, please contact:<\/p>\n<p>\nMaren Thurow, Head Global Communications at Gr\u00fcnenthal<\/p>\n<p>\nmaren.thurow@grunenthal.com<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Informaci\u00f3n remitida por la empresa firmante) Aachen, Germany, 20th May 2025 (News Aktuell) .- Maren Thurow has today assumed the role of Vice President and Head Global Communications at Gr\u00fcnenthal. She succeeds Florian Dieckmann, who has played a key role in evolving the company\u2019s Communications department since 2021. In her new position, Maren will oversee [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-61588","post","type-post","status-publish","format-standard","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/61588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=61588"}],"version-history":[{"count":0,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/61588\/revisions"}],"wp:attachment":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=61588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=61588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=61588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}